STOCK OPTIONS

6 Months Ended

Apr. 30, 2026

Share-Based Payment Arrangement [Abstract]

STOCK OPTIONS

NOTE 8: STOCK OPTIONS

On August 19, 2025, the Company adopted the Helio Corporation 2025 Equity Incentive Plan (the “2025 Plan”), which was also approved by the Company’s stockholders on August 19, 2025. The 2025 Plan is intended to assist the Company in recruiting and retaining employees, officers, directors, and consultants, and to provide incentives tied to increases in the value of the Company’s equity. Unless terminated earlier by the Board, the 2025 Plan will terminate on August 19, 2035, and no awards may be granted after that date.

The 2025 Equity Plan limits the shares of common stock authorized to be awarded as stock awards to 2,382,352 shares as of April 30, 2026 and October 31, 2025, respectively. Employees are provided stock options vesting over a period of four years with a one year cliff. After one year, 25% of the award size vests followed by 1/48^th of the award size for each month thereafter. On a case-by-case basis, options have been granted outright with no vest period.

Due to the change-in-control transaction described in Note 1, there was a recapitalization for which the Company’s stock options were adjusted for the new capital structure. The Company adjusted each of the granted options a 0.612 factor.

During the three and six months ended April 30, 2026 and 2025, there were no stock options granted.

Number of
Shares

Weighted Average
Exercise
Price ($)

Weighted
Average
Remaining
Term
(Three months)

Aggregate
Intrinsic
Value

Three and six months ended April 30, 2025

Balance as of October 31, 2024

1,422,307

$

0.09

7.02

$

6,980,951

Issued

–

–

–

–

Canceled

–

–

–

–

Exercised

–

–

–

–

Balance as of January 31, 2025

1,422,307

$

0.09

6.77

$

6,980,951

Issued

–

–

–

–

Canceled

–

–

–

–

Exercised

–

–

–

–

Balance as of April 30, 2025

1,422,307

$

0.09

6.52

$

6,980,951

Three and six months ended April 30, 2026

Balance as of October 31, 2025

1,750,971

$

0.43

6.73

$

438,197

Issued

–

–

–

–

Canceled

–

–

–

–

Exercised

–

–

–

–

Balance as of January 31, 2026

1,750,971

$

0.43

6.48

$

1,618,854

Issued

–

–

–

–

Canceled

–

–

–

–

Exercised

52,604

$

0.09

–

–

Balance as of April 30, 2026

1,698,367

$

0.44

6.23

$

3,298,610

Exercisable as of April 30, 2026

1,615,129

$

0.45

6.18

$

3,227,960

Stock-based compensation from stock awards for the six months ended April 30, 2026 and 2025 was $59,381 and $87,754, respectively. Stock-based compensation from stock awards for the three months ended April 30, 2026 and 2025 was $26,997 and $41,257, respectively. As of April 30, 2026 and October 31, 2025, there remained $51,600 and $110,981 of unrecognized stock-based compensation from stock option awards, respectively. As of April 30, 2026, there were 1,615,129 shares of common stock related to stock option grants that were vested and 83,238 stock option grants that were unvested.